UBS raised the firm’s price target on Axon (AXON) to $840 from $820 and keeps a Neutral rating on the shares. Axon’s growth reaccelerated in Q2, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon upgraded to Buy from Hold at Craig-Hallum
- Axon Enterprise’s Strong Growth Potential and Increased Price Target Amid Surpassing Revenue Expectations
- Axon Enterprise’s Strong Financial Performance and Strategic Growth Drive Buy Rating
- Axon Enterprise Reports Strong Q2 2025 Growth
- Axon Enterprise’s Strong Revenue Growth and Bookings Performance Justify Buy Rating and Increased Price Target